Concerta en es it fr

Concerta Brand names, Concerta Analogs

Concerta Brand Names Mixture

  • No information avaliable

Concerta Chemical_Formula


Concerta RX_link

Concerta fda sheet

Concerta FDA

Concerta msds (material safety sheet)

Concerta MSDS

Concerta Synthesis Reference

M. Hartmann, L. Panizzon, U.S. Pat. 2,507,631 (1950)

Concerta Molecular Weight

233.306 g/mol

Concerta Melting Point


Concerta H2O Solubility


Concerta State


Concerta LogP


Concerta Dosage Forms

Tablets; Tablets (sustained release)

Concerta Indication

For use as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity.

Concerta Pharmacology

Methylphenidate is a central nervous system stimulant used most commonly in the treatment of attention-deficit disorders in children and for narcolepsy. Its mechanisms appear to be similar to those of dextroamphetamine.

Concerta Absorption

Readily absorbed in a biphasic manner. It reaches peak absorption at approximately two hours for the first phase and five hours for the second phase. Bioavailability is low (approximately 30%)

Concerta side effects and Toxicity

Symptoms of overdose include vomiting, agitation, tremors, hyperreflexia, muscle twitching, convulsions (may be followed by coma), euphoria, confusion, hallucinations, delirium, sweating, flushing, headache, hyperpyrexia, tachycardia, palpitations, cardiac arrhythmias, hypertension, mydriasis, and dryness of mucous membranes. LD50=190mg/kg (orally in mice)

Concerta Patient Information

Concerta Organisms Affected

Humans and other mammals